A major discovery in cancer study is arising with the use of VHH fragments to re-engage mutated p53. This crucial malignant inhibitor protein is frequently disabled in several forms of malignancies, leading https://bookmarkprobe.com/story22225374/mini-antibodies-revive-tumor-suppressor-p53-new-new-hope-for-cancer-treatment